KalVista Pharmaceuticals (NASDAQ:KALV) CEO Sells $120,423.94 in Stock

KalVista Pharmaceuticals (NASDAQ:KALV) CEO Sells $120,423.94 in Stock

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Get Free Report) CEO Benjamin Palleiko sold 7,294 shares of the firm's stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $16.51, for a total transaction of $120,423.94. Following the transaction, the chief executive officer directly owned 424,520 shares in the company, valued at approximately $7,008,825.20. The trade was a 1.69% decrease in their position.…

Benjamin Palleiko Sells 7,294 Shares of KalVista Pharmaceuticals (NASDAQ:KALV) Stock

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) CEO Benjamin Palleiko sold 7,294 shares of the firm’s stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $16.51, for a total value of $120,423.94. Following the sale, the chief executive officer owned 424,520 shares of the […]